Vireo Growth (VREOF) EBT Margin (2020 - 2026)
Vireo Growth's (VREOF) quarterly EBT Margin came in at 3.95% in Q1 2026, up 1564.0% year-on-year from 0.24% in Q1 2025, and up 65.69% quarter-over-quarter from 11.53% in Q4 2025.
Vireo Growth (VREOF) EBT Margin (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed EBT Margin across 7 years of filings, most recently posting 3.95% for Q1 2026.
- EBT Margin for Q1 2026 came in at 3.95%, up 1564.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.21% (up 776.0% YoY), and the FY2025 annual result was 14.85%, up 215.0% from the prior year.
- EBT Margin came in at 3.95% for Q1 2026 at Vireo Growth, up from 11.53% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 0.91% in Q2 2024 to a low of 104.27% in Q1 2022.
- The 5-year median for EBT Margin is 19.59% (2025), against an average of 25.42%.
- Across the five-year window, EBT Margin plunged 6351 bps in 2022 and soared 6894 bps in 2023, its largest moves.
- Vireo Growth's EBT Margin stood at 38.52% in 2022, then soared by 61 bps to 14.87% in 2023, then plunged by 205 bps to 45.39% in 2024, then soared by 75 bps to 11.53% in 2025, then soared by 66 bps to 3.95% in 2026.
- The last three EBT Margin figures came in at 3.95% (Q1 2026), 11.53% (Q4 2025), and 14.13% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Vireo Growth | - | - | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.95% |
| Dec 31, 2025 | -11.53% |
| Sep 30, 2025 | -14.13% |
| Jun 30, 2025 | -20.97% |
| Mar 31, 2025 | -19.59% |
| Dec 31, 2024 | -45.39% |
| Sep 30, 2024 | -10.10% |
| Jun 30, 2024 | -0.91% |
| Mar 31, 2024 | -11.49% |
| Dec 31, 2023 | -14.87% |
| Sep 30, 2023 | -7.09% |
| Jun 30, 2023 | -28.40% |
| Mar 31, 2023 | -35.33% |
| Dec 31, 2022 | -38.52% |
| Sep 30, 2022 | -41.28% |
| Jun 30, 2022 | -24.36% |
| Mar 31, 2022 | -104.27% |
| Dec 31, 2021 | -86.26% |
| Sep 30, 2021 | -47.20% |
| Jun 30, 2021 | -42.88% |